Nuclear basic fibroblast growth factor regulates triple-negative breast cancer chemo-resistance
Conclusion:
These studies identify nuclear bFGF as a protein in a subset of TN breast cancers that likely contributes to drug resistance following standard chemotherapy treatment.
Source: Breast Cancer Research - Category: Cancer & Oncology Authors: Shenduo LiSturgis PayneFang WangPeter ClausZuowei SuJeffrey GrothJoseph GeradtsGustaaf de RidderRebeca AlvarezPaul MarcomSalvatore PizzoRobin Bachelder Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Chemotherapy | Gastroschisis Repair | Genetics | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy | Study